The popularity of Sildenafil initially fueled a period of growth for pharma, however recent developments present a uncertain outlook for shareholders. Off-patent alternatives are eating into earnings, and ongoing legal https://flynnigsq637715.blogpixi.com/41524485/viagra-and-big-pharma-a-precarious-play